MACKENZIE FINANCIAL CORP - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 10.51 and the average weighting 0.3%.

Quarter-by-quarter ownership
MACKENZIE FINANCIAL CORP ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$282,000
-84.7%
2,524
-90.0%
0.00%
-83.3%
Q1 2020$1,838,000
-38.1%
25,280
+15.5%
0.01%
-25.0%
Q4 2018$2,970,000
-70.0%
21,887
-39.4%
0.01%
-66.7%
Q3 2018$9,910,000
+275.2%
36,102
+63.1%
0.02%
+60.0%
Q2 2016$2,641,000
+10.9%
22,141
-0.4%
0.02%
-31.8%
Q1 2016$2,382,00022,2410.02%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Knott David M Jr 115,000$8,4593.32%
VILLERE ST DENIS J & CO LLC 480,807$35,368,1622.57%
Chicago Capital, LLC 449,508$33,065,8221.64%
RICE HALL JAMES & ASSOCIATES, LLC 288,345$21,210,6811.20%
Smith, Graham & Co., Investment Advisors, LP 65,163$4,793,3900.58%
Stephens Investment Management Group LLC 455,089$33,476,3470.56%
CARDINAL CAPITAL MANAGEMENT LLC /CT 201,993$14,858,6050.53%
WOODSTOCK CORP 52,604$3,869,5500.49%
Court Place Advisors, LLC 15,533$1,142,6070.41%
Jackson Creek Investment Advisors LLC 12,726$9360.39%
View complete list of LIGAND PHARMACEUTICALS INC shareholders